| Page 1307 | Kisaco Research
 

Nikki Jessop

National Biosimilar and Speciality Commercial Lead
Zentiva

Nikki Jessop

National Biosimilar and Speciality Commercial Lead
Zentiva

Nikki Jessop

National Biosimilar and Speciality Commercial Lead
Zentiva
 

Nicholas Pourbaix

Associate General Counsel
Amgen

Nicholas Pourbaix

Associate General Counsel
Amgen

Nicholas Pourbaix

Associate General Counsel
Amgen
 

Ha Kung Wong

Partner, Advisory Board Member
Venable, Centre for Biosimilars

Ha Kung Wong has over 20 years of experience practicing general intellectual property law with an emphasis on complex patent and trade secret litigation as well as IP transactions and contract negotiations for mergers, acquisitions, and collaborations in pharmaceuticals, biologics, and chemistry. Cases Mr. Wong has litigated include those related to proton pump inhibitors, allergy eye drops, anti-epileptic drugs, anti-tussive, injectable microspheres, RNAi products, and other pharmaceuticals. Mr.

Ha Kung Wong

Partner, Advisory Board Member
Venable, Centre for Biosimilars

Ha Kung Wong

Partner, Advisory Board Member
Venable, Centre for Biosimilars

Ha Kung Wong has over 20 years of experience practicing general intellectual property law with an emphasis on complex patent and trade secret litigation as well as IP transactions and contract negotiations for mergers, acquisitions, and collaborations in pharmaceuticals, biologics, and chemistry. Cases Mr. Wong has litigated include those related to proton pump inhibitors, allergy eye drops, anti-epileptic drugs, anti-tussive, injectable microspheres, RNAi products, and other pharmaceuticals. Mr. Wong also has extensive experience with Inter Partes Review, Post Grant Review, intellectual property counseling, pharmaceutical regulatory counseling, pre-suit investigations, licensing, and due diligence.

Mr. Wong has his BS with high distinction in Chemistry and his BS in Biochemistry from the University of Illinois Urbana-Champaign and his JD, cum laude, from the University of Notre Dame. Mr. Wong is currently an elected member of the Venable Board, is an Advisory Board Member for the Center for Biosimilars, is Treasurer, Executive Committee member, and Board Trustee for the Foundation for Advancement of Diversity in IP Law (FADIPL) and serves as faculty for the National Institute of Trial Advocacy (NITA) and Lawline.

 

Dr. Leslie Fischer

Principal Patent Attorney
Sandoz

Leslie Fischer is a Principal Patent Attorney at Sandoz, who focuses on global IP strategy for biosimilars. Before joining Sandoz, Leslie was a patent attorney at Novartis Pharmaceuticals, where she worked for over a decade developing global patent portfolios for biologicals. Before joining the Novartis group, Leslie was an associate at Fitzpatrick Cella (NY) (now Venable). Leslie holds a J.D. from Rutgers University and a Ph.D. in Biochemistry from Thomas Jefferson University. Her scientific work appears in JCB, JBC, and Osteoarthritis & Cartilage.

Dr. Leslie Fischer

Principal Patent Attorney
Sandoz

Dr. Leslie Fischer

Principal Patent Attorney
Sandoz

Leslie Fischer is a Principal Patent Attorney at Sandoz, who focuses on global IP strategy for biosimilars. Before joining Sandoz, Leslie was a patent attorney at Novartis Pharmaceuticals, where she worked for over a decade developing global patent portfolios for biologicals. Before joining the Novartis group, Leslie was an associate at Fitzpatrick Cella (NY) (now Venable). Leslie holds a J.D. from Rutgers University and a Ph.D. in Biochemistry from Thomas Jefferson University. Her scientific work appears in JCB, JBC, and Osteoarthritis & Cartilage. She speaks frequently at patent-related events and is an adjunct professor at Seton Hall Law School.

 

Christof Bull

Assistant General Patent Counsel
UCB

Christof Bull

Assistant General Patent Counsel
UCB

Christof Bull

Assistant General Patent Counsel
UCB
 

Vivek Lal

CEO
Alveolus Bio

Vivek Lal

CEO
Alveolus Bio

Vivek Lal

CEO
Alveolus Bio
 

Robert JM Brummer MD PhD

Pro-Vice-Chancellor, Food & Health
Orebro University

Robert JM Brummer MD PhD

Pro-Vice-Chancellor, Food & Health
Orebro University

Robert JM Brummer MD PhD

Pro-Vice-Chancellor, Food & Health
Orebro University
 

Rikke Nielson

CEO
BEO Therapeutics

Rikke Nielson

CEO
BEO Therapeutics

Rikke Nielson

CEO
BEO Therapeutics